BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Aqilion announces pre-clinical licensing and strategic research collaboration agreement with Merck

In addition, Aqilion is eligible to receive potential development and commercialization milestones up to over EUR 950 million and tiered royaltie...

February 17, 2023 | News

Biotage strengthens its position as a global chromatography leader with the transformative acquisition of Astrea Bioseparations

Biotage has entered into an agreement to acquire Astrea Bioseparations, a high-growth chromatography solutions provider from Gamma Biosciences, a global li...

February 15, 2023 | News

Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin

Sale of assets related to Flow Cytometry & Imaging (FCI) Business Unit Acquisition will expand Cytek’s product portfolio to include imaging an...

February 14, 2023 | News

Biosynth’s Peptide Division successfully completed GMP inspection in Lelystad

Biosynth announces that its site in Lelystad, The Netherlands, successfully passed the recent GMP inspection by the Inspectie Gezondheidszorg en Jeug...

February 09, 2023 | News

Dolomite Bio announces re brand to Do Bio

The expertise behind Do bio’s technology is built on a strong foundation in the field of microfluidics. As the company has grown in recent years, the...

February 09, 2023 | News

Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease

The two induction cohorts missed the co-primary endpoints of clinical remission and endoscopic response at Week 10 In the maintenance phase, filgotinib ...

February 09, 2023 | News

Pharmapack Europe Awards Winners 2023

Pharmapack Europe (#PharmapackEU) announces the winners of the prestigious 2023 Pharmapack Awards spanning five categories across two dedicated awards. Th...

February 09, 2023 | News

Recce Pharmaceuticals Announces RECCE® Trademark Registered in Hong Kong

Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, today announced that it has ...

February 03, 2023 | News

TransCure bioServices offers BioVolume 3D imaging for insightful preclinical oncology research

TransCure bioServices adds BioVolume 3D imaging to its service offerings, enabling them to deliver even higher quality tumor growth results to customers. W...

February 02, 2023 | News

Theramex select CARA Life Sciences Platform to consolidate and digitise regulatory processes

Theramex, headquartered in London, UK, is a global speciality pharmaceutical company which produce women’s health products and operate in more than 8...

February 02, 2023 | News

Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market

Clinical development pipeline is essential to global business strategy Vetter Development Service offers comprehensive expertise for in-human trial mate...

February 02, 2023 | News

Eppendorf & Science Prize for Neurobiology 2023 Call for Entries!

This annual international research prize of US$25,000 is awarded to young scientists for their outstanding contributions to neurobiological research based ...

February 02, 2023 | News

TransCode Therapeutics Reports Positive Preclinical Results with its Immunotherapy Candidate, TTX-RIGA, in Melanoma

TransCode Therapeutics, Inc. (Nasdaq: RNAZ), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today repor...

February 01, 2023 | News

Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement

Consolidated Manufacturing, Sales, Marketing, Operations to Provide Synergistic Cost Savings Biosynex SA (“Biosynex”) (EPA: ALBIO), a French m...

February 01, 2023 | News

Stay Connected